Biolargo, Inc. financial data

Symbol
BLGO on OTC
Industry
Chemicals & Allied Products
Location
14921 Chestnut St., Westminster, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
NUWAY MEDICAL INC (to 4/3/2007), NUWAY ENERGY INC (to 2/5/2003), LATIN AMERICAN CASINOS INC (to 2/15/2001)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 235 % -14.7%
Quick Ratio 8.11 % +13.9%
Debt-to-equity 55.8 % +24.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 301M shares +1.95%
Common Stock, Shares, Outstanding 293M shares +5.2%
Entity Public Float 61.4M USD +50.1%
Common Stock, Value, Issued 202K USD +3.06%
Weighted Average Number of Shares Outstanding, Basic 298M shares +4.25%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.88M USD +26.3%
Operating Income (Loss) -4.33M USD +5.44%
Earnings Per Share, Basic -0.01 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.55M USD +0.25%
Accounts Receivable, after Allowance for Credit Loss, Current 3.17M USD +21.3%
Inventory, Net 330K USD +116%
Assets, Current 7.14M USD +12.2%
Property, Plant and Equipment, Net 1.74M USD +163%
Operating Lease, Right-of-Use Asset 992K USD -9.16%
Other Assets, Noncurrent 95K USD +35.7%
Assets 10.5M USD +28.1%
Accounts Payable, Current 826K USD -31.8%
Employee-related Liabilities, Current 120K USD -52.2%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 2.65M USD -2.29%
Operating Lease, Liability, Noncurrent 922K USD -8.17%
Liabilities 4.46M USD +11.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -183K USD +33.9%
Retained Earnings (Accumulated Deficit) -150M USD -1.63%
Stockholders' Equity Attributable to Parent 8.85M USD +29.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.06M USD +44.1%
Liabilities and Equity 10.5M USD +28.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 481K USD
Net Cash Provided by (Used in) Financing Activities 1.08M USD -28.3%
Net Cash Provided by (Used in) Investing Activities -863K USD -1698%
Common Stock, Shares Authorized 550M shares 0%
Common Stock, Shares, Issued 301M shares +2.84%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 797K USD -43.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12K USD -20%
Deferred Tax Assets, Valuation Allowance 22.5K USD +1.14%
Operating Lease, Liability 1.03M USD -7.39%
Depreciation 155K USD +50.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.31M USD +36.5%
Lessee, Operating Lease, Liability, to be Paid 1.77M USD -7.35%
Property, Plant and Equipment, Gross 2.2M USD +115%
Operating Lease, Liability, Current 105K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 289K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 282K USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.18 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 739K USD -20.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 296K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 22.5K USD +1.14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 245K USD 0%
Additional Paid in Capital 158M USD +2.8%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 45K USD -47.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%